Literature DB >> 21294757

Effects of acetaldehyde on hepatocyte glycerol uptake and cell size: implication of aquaporin 9.

James J Potter1, Ayman Koteish, James Hamilton, Xiaopu Liu, Kun Liu, Peter Agre, Esteban Mezey.   

Abstract

BACKGROUND: The effects of ethanol and acetaldehyde on uptake of glycerol and on cell size of hepatocytes and a role Aquaporin 9 (AQP9), a glycerol transport channel, were evaluated.
METHODS: The studies were done in primary rat and mouse hepatocytes. The uptake of [(14) C] glycerol was determined with hepatocytes in suspension. For determination of cell size, rat hepatocytes on coated dishes were incubated with a lipophilic fluorochrome that is incorporated into the cell membrane and examined by confocal microscopy. A three-dimensional z scan of the cell was performed, and the middle slice of the z scan was used for area measurements.
RESULTS: Acute exposure to acetaldehyde, but not to ethanol, causes a rapid increase in the uptake of glycerol and an increase in hepatocyte size, which was inhibited by HgCl(2) , an inhibitor of aquaporins. This was not observed in hepatocytes from AQP9 knockout mice, nor observed by direct application of acetaldehyde to AQP9 expressed in Xenopus Laevis oocytes. Prolonged 24-hour exposure to either acetaldehyde or ethanol did not result in an increase in glycerol uptake by rat hepatocytes. Acetaldehyde decreased AQP9 mRNA and AQP9 protein, while ethanol decreased AQP9 mRNA but not AQP9 protein. Ethanol, but not acetaldehyde, increased the activities of glycerol kinase and phosphoenolpyruvate carboxykinase.
CONCLUSIONS: The acute effects of acetaldehyde, while mediated by AQP9, are probably influenced by binding of acetaldehyde to hepatocyte membranes and changes in cell permeability. The effects of ethanol in enhancing glucose kinase, and phosphoenolpyruvate carboxykinase leading to increased formation of glycerol-3-phosphate most likely contribute to alcoholic fatty liver.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294757      PMCID: PMC3083478          DOI: 10.1111/j.1530-0277.2010.01424.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  27 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  Acetaldehyde and microtubules.

Authors:  D J Tuma; S L Smith; M F Sorrell
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

Review 3.  Morphology of alcoholic liver disease.

Authors:  Jay H Lefkowitch
Journal:  Clin Liver Dis       Date:  2005-02       Impact factor: 6.126

Review 4.  Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.

Authors:  Charles S Lieber
Journal:  Alcohol       Date:  2004-08       Impact factor: 2.405

5.  Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat.

Authors:  Colleen K Nye; Richard W Hanson; Satish C Kalhan
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

6.  Aquaglyceroporin PbAQP during intraerythrocytic development of the malaria parasite Plasmodium berghei.

Authors:  Dominique Promeneur; Yangjian Liu; Jorge Maciel; Peter Agre; Landon S King; Nirbhay Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

7.  Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.

Authors:  Jin-Hyung Lee; Atrayee Banerjee; Yoshi Ueno; Shashi K Ramaiah
Journal:  Toxicol Sci       Date:  2008-08-14       Impact factor: 4.849

8.  Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice.

Authors:  Aleksandra M Rojek; Mariusz T Skowronski; Ernst-Martin Füchtbauer; Annette C Füchtbauer; Robert A Fenton; Peter Agre; Jørgen Frøkiaer; Søren Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

9.  Ethanol increases hepatocyte water volume.

Authors:  R Wondergem; J Davis
Journal:  Alcohol Clin Exp Res       Date:  1994-10       Impact factor: 3.455

10.  PPARalpha and PPARbeta are differentially affected by ethanol and the ethanol metabolite acetaldehyde in the MCF-7 breast cancer cell line.

Authors:  Nagaraj Gopisetty Venkata; Cho S Aung; Peter J Cabot; Gregory R Monteith; Sarah J Roberts-Thomson
Journal:  Toxicol Sci       Date:  2007-11-13       Impact factor: 4.109

View more
  5 in total

1.  Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.

Authors:  Amaia Rodríguez; Victoria Catalán; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

2.  Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.

Authors:  A Rodríguez; P Gena; L Méndez-Giménez; A Rosito; V Valentí; F Rotellar; I Sola; R Moncada; C Silva; M Svelto; J Salvador; G Calamita; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2013-12-13       Impact factor: 5.095

3.  Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.

Authors:  Amaia Rodríguez; Natalia R Moreno; Inmaculada Balaguer; Leire Méndez-Giménez; Sara Becerril; Victoria Catalán; Javier Gómez-Ambrosi; Piero Portincasa; Giuseppe Calamita; Graça Soveral; María M Malagón; Gema Frühbeck
Journal:  Sci Rep       Date:  2015-07-10       Impact factor: 4.379

4.  Protective Effects of Ligularia fischeri and Aronia melanocarpa Extracts on Alcoholic Liver Disease (In Vitro and In Vivo Study).

Authors:  Chang-Won Pyun; Tae-Su Seo; Dae-Jung Kim; Tae-Woo Kim; Jung-Shik Bae
Journal:  Biomed Res Int       Date:  2020-04-14       Impact factor: 3.411

Review 5.  Aquaglyceroporins: Drug Targets for Metabolic Diseases?

Authors:  Giuseppe Calamita; Jason Perret; Christine Delporte
Journal:  Front Physiol       Date:  2018-07-10       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.